Piribedil
- Generic Name
- Piribedil
- Drug Type
- Small Molecule
- Chemical Formula
- C16H18N4O2
- CAS Number
- 3605-01-4
- Unique Ingredient Identifier
- DO22K1PRDJ
Overview
Piribedil has been investigated in Parkinson's Disease.
Background
Piribedil has been investigated in Parkinson's Disease.
Indication
适用于治疗帕金森病和帕金森综合症，对震颤作用强，对强直和少动的作用较弱。亦可用于老年患者的慢性病理性认知和感觉神经障碍的辅助性症状性治疗，下肢慢性阻塞性动脉病所致的间歇性跛行的辅助性治疗。
Associated Conditions
- Parkinson's Disease (PD)
Clinical Trials
FDA Approved Products
No FDA products found for this drug
Singapore Approved Products
TRIVASTAL RETARD 50 TABLET 50 mg
Manufacturer:LES LABORATOIRES SERVIER INDUSTRIE
Form:TABLET, FILM COATED
Strength:50 mg
Online:Yes
Approved: 1998/08/22
Approval:SIN09947P
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath